DNA topoisomerase 4 subunit A

Description:

Description
  • Accession: P0C1U9
  • Swissprot: PARC_STAAU
  • Organism: Staphylococcus aureus
  • Gene: parC
  • Target class: Enzyme

Drug Relations:

ciprofloxacin
A broad-spectrum antimicrobial carboxyfluoroquinoline. Bioactivity details MOA
gatifloxacin
A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS. Bioactivity details MOA
gemifloxacin
A naphthyridine and fluoroquinolone derivative antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used for the treatment of community-acquired pneumonia and acute bacterial infections associated with chronic bronchitis. Bioactivity details MOA
moxifloxacin
A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent. Bioactivity details MOA
norfloxacin
A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. Bioactivity details MOA